Targeting ATAD3A phosphorylation with the peptide TAT‐PEP shows exceptional anti‐aging and anti‐tumor effects, providing a potential therapeutic strategy for combating aging and aging‐associated disorders. This evidence concerns the gene ATAD3A and neoplasm.